Yi Wan | Point-of-Care Testing | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Yi Wan | Point-of-Care Testing | Best Researcher Award

Dean | Hainan University | China

Dr. Yi Wan is a distinguished scientist at Hainan University, Haikou, China, recognized internationally for his exceptional contributions to nanomaterials, biosensing, polymer chemistry, and molecular diagnostics. With an impressive portfolio of 84 peer-reviewed publications, his research has garnered 3,169 citations, demonstrating a remarkable h-index of 32, which reflects both the depth and consistent influence of his scientific output. Dr. Wan’s multidisciplinary work focuses on the design and application of advanced biomaterials and molecular tools for rapid and precise pathogen detection, bridging the gap between laboratory innovation and clinical implementation. His pioneering studies, such as “Ultrasensitive detection of clinical pathogens through a target-amplification-free collateral-cleavage-enhancing CRISPR-CasΦ tool” published in Nature Communications, and “Synthesis, Characterization, and Cytotoxic Activity of Stable Selenium Nanoparticles-Incorporated Carboxymethylcellulose Solution” in Polymers for Advanced Technologies, exemplify his commitment to developing next-generation biosensors and functionalized materials for healthcare and environmental monitoring. Beyond these, his influential research appears in renowned journals including Biosensors and Bioelectronics, Sensors and Actuators B: Chemical, and Analyst, where he advances the frontiers of molecular diagnostics, PAM-free CRISPR-based assays, and microfluidic-driven detection systems. Over his career, Dr. Wan has collaborated with more than 200 international co-authors and contributed to 11 preprints, reflecting his strong global research network and dedication to open scientific exchange. His investigations into the supramolecular structure of cellulose, biopolymer modification, and nanomaterial toxicity provide new insights into sustainable biomaterial applications and translational bioscience. Through his relentless pursuit of innovation, Dr. Wan has positioned himself as a leading voice in the integration of biotechnology, chemistry, and engineering to address emerging global health challenges. His scholarly impact, reflected through extensive publication output, high citation metrics, and international collaborations, underscores his reputation as a visionary researcher driving the evolution of molecular engineering, diagnostic technology, and sustainable biomedical solutions.

Profiles: Scopus | Google Scholar

Featured Publications

Asma Rehman | General Chemistry | Innovative Research Award

Published on by Medical Lab Scientist

Ms. Asma Rehman | General Chemistry | Innovative Research Award

Researcher | University of Agriculture Fasilabad | Pakistan

Asma Rehman is an emerging chemist and researcher from the University of Agriculture, Faisalabad, Pakistan, with a strong academic foundation in green and sustainable chemistry. She earned her Bachelor’s degree in Chemistry from Government College University, Faisalabad, and completed her M.Phil. at the University of Agriculture, focusing on organocatalysis, polymer degradation, and the application of artificial intelligence for process modeling and optimization. Her research integrates experimental chemistry with computational approaches to design environmentally benign catalytic systems for the degradation and upcycling of polystyrene, contributing to sustainable polymer chemistry and circular economy initiatives. Asma has co-authored three peer-reviewed publications in reputable international journals, including RSC Advances (“A green marriage: the union of theophylline’s catalytic activity and healing potential, “Nickel-photoredox catalysis: merging photons with metal catalysts for organic synthesis, and AI (“Artificial Intelligence-Guided Supervised Learning Models for Photocatalysis in Wastewater Treatment. Her interdisciplinary expertise bridges chemistry and artificial intelligence, enabling innovative, data-driven insights into sustainable materials and environmental remediation. With an h-index of 2 and 3 indexed research documents, Asma’s scholarly contributions demonstrate her commitment to advancing green chemistry and smart catalysis. Her ongoing research aims to develop scalable catalytic processes that align with the United Nations Sustainable Development Goals, emphasizing responsible production, clean technologies, and climate action for a more sustainable future.

Profile: ORCID

Featured Publications

1. Rehman, A., Ahad, A., Majeed, A., Zafar, A., Iqbal, M. A., Ali, S., Batool, M., & Manzoor, F. (2025). A green marriage: The union of theophylline’s catalytic activity and healing potential. RSC Advances.

2. Rehman, A., Manzoor, F., Majeed, A., Ibrahim, A. H., Iqbal, M. A., Aziz, S., Shahzadi, A., Fatima, S., Ejaz, S., & Zafar, M. S. (2025). Nickel-photoredox catalysis: Merging photons with metal catalysts for organic synthesis.

3. Rehman, A., Iqbal, M. A., Haider, M. T., & Majeed, A. (2025). Artificial intelligence-guided supervised learning models for photocatalysis in wastewater treatment. AI, 6(10), 258.

4. Rehman, A., & Majeed, A. (2024). Organocatalytic valorization of polymer waste: Sustainable approaches toward circular chemistry. Journal of Environmental Chemical Engineering.

5. Rehman, A., Iqbal, M. A., & Manzoor, F. (2025). AI-assisted modeling for predicting catalytic reaction kinetics in green polymer degradation. Computational Chemistry Letters. (In preparation)

David Karnak | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. David Karnak | Biochemistry | Best Researcher Award

Senior Research Specialist | University of Michigan | United States

Dr. David M. Karnak, Ph.D., is the Managing Director of the Experimental Radiation Shared Resource and Senior Research Specialist in the Department of Radiation Oncology at the University of Michigan. He earned his B.S. in Chemistry (Biochemistry concentration) from the University of Dayton and a Ph.D. in Biological Chemistry from the University of Michigan, where his doctoral work elucidated structural mechanisms of L27 domain-mediated protein interactions critical to cell polarity. Over his two-decade research career, Dr. Karnak has advanced the understanding of radiation sensitization, DNA damage response modulation, and the integration of conformal and FLASH radiotherapy in preclinical oncology models. His interdisciplinary expertise bridges biochemistry, molecular oncology, and translational radiation biology, contributing to numerous collaborative studies published in leading journals including Molecular Cancer Research, Clinical Cancer Research, Cell Reports, and Molecular Cell. With 29 peer-reviewed publications, 1,871 citations from 29 documents, and an h-index of 20, Dr. Karnak’s research has significantly influenced experimental radiation oncology and precision cancer therapy development. Beyond research, he leads efforts to enhance small-animal radiobiology platforms (SARRP) for translational cancer studies and mentors undergraduate and graduate trainees in experimental therapeutics. His current work focuses on integrating immunoradiotherapy paradigms and DNA repair pathway inhibitors to improve treatment outcomes in pancreatic and hepatic malignancies. Dr. Karnak’s leadership and innovative contributions continue to support the University of Michigan’s role as a global leader in cancer biology and radiation research.

Profiles: Scopus | ORCID

Featured Publications

1. Karnak D, Engelke C.G., Parsels L.A., Kausar T., Wei D., Robertson J.R., Marsh K.B., Davis M.A., Zhao L., Maybaum J., Lawrence T.S., Morgan M.A. (2014). Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancer. Clinical Cancer Research, 20(19): 5085–5096.

2. Parsels L.A., Karnak D., Parsels J.D., Zhang Q., Vélez-Padilla J., Reichert Z.R., Wahl D.R., Maybaum J., O’Connor M.J., Lawrence T.S., Morgan M.A. (2018). PARP1 trapping and DNA replication stress enhance radiosensitization with combined WEE1 and PARP inhibitors. Molecular Cancer Research, 16(2): 222–232.

3. Wang W., McMillan M.T., Zhao X., Wang Z., Jiang L., Karnak D., Lima F., Parsels J.D., Parsels L.A., Lawrence T.S., Frankel T.L., Morgan M.A., Green M.D., Zhang Q. (2022). DNA-PK inhibition and radiation promote antitumoral immunity through RNA Polymerase III in pancreatic cancer. Molecular Cancer Research, 20(7): 1137–1150.

4. Chefetz I., Grimley E., Yang K., Hong L., Vinogradova E.V., Suciu R., Kovalenko I., Karnak D., Morgan C.A., et al. (2019). A pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells. Cell Reports, 26(11): 3061–3075.

5. Valvo V.M., Zhang Q., Jiang L., Holcomb E.A., Pearson A.N., Edmunds A.G., Faulkner H.G., James J.G., Tate A., Huber A., Wang Z., Guo Y., Karnak D., et al. (2025). Olaparib and radiotherapy induce type I interferon and CD8+ T cell-dependent sensitization to immunotherapy in pancreatic cancer. Molecular Cancer Therapeutics, 24(6): 843–858.

Atsushi Hosui | Research Methods in Medical Lab Science | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Atsushi Hosui | Research Methods in Medical Lab Science | Best Researcher Award

Atsushi Hosui | Osaka Rosai Hospital | Japan

Dr. Atsushi Hosui, MD, PhD, is the Chief Director of the Department of Gastroenterology at Osaka Rosai Hospital and a Clinical Professor at Osaka University Medical School. A graduate of Osaka University’s School of Medicine in 1994, he obtained his Doctor of Medicine in 2003 and pursued advanced research training at the U.S. National Institutes of Health (NIH). Over the past two decades, Dr. Hosui has established himself as a leading figure in hepatology, liver regeneration, and hepatocellular carcinoma (HCC) research. His pioneering studies have significantly advanced understanding of cytokine-controlled STAT signaling pathways, zinc metabolism, and molecular mechanisms underlying liver carcinogenesis and regeneration. He has authored 71 Scopus-indexed publications, amassing 2,663 citations, with an impressive h-index of 26, reflecting the global influence and sustained impact of his scholarly work. His landmark publications in The Journal of Biological Chemistry, Hepatology, and Hepatol Communications have made vital contributions to translational hepatology, bridging laboratory research with clinical applications. Dr. Hosui also serves as Academic Editor for PLOS One and Associate Editor for Frontiers in Pharmacology, underscoring his editorial leadership and international recognition. In addition to his research achievements, he plays a pivotal role in mentoring early-career hepatologists and leading collaborative projects on zinc supplementation, liver fibrosis, and HCC prevention. Through his commitment to scientific innovation, education, and patient-centered research, Dr. Hosui continues to elevate the standards of hepatology, making him an outstanding candidate for the Research for Best Researcher Award.

Profiles: ORCID | Scopus

Featured Publications

Ding Wen Wu | Transfusion Medicine | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Ding Wen Wu | Transfusion Medicine | Best Researcher Award

Professor | NYU Grossman School of Medicine | United states 

Prof. Ding Wen Wu is a distinguished researcher and educator in the field of transfusion medicine, currently affiliated with the NYU Grossman School of Medicine, United States. With a career dedicated to advancing patient blood management and diagnostic innovation, he has made notable contributions that bridge laboratory research and real-world clinical practice. His research focuses on improving transfusion safety, optimizing resource utilization, and promoting evidence-based approaches that enhance healthcare efficiency and patient outcomes. Prof. Wu’s academic profile demonstrates strong scholarly impact, with 10 published scientific documents, 97 citations, and an h-index of 3, reflecting the quality and growing influence of his work within the international medical community. His studies have appeared in highly respected journals such as JAMA Internal Medicine, Life, Healthcare, and the Journal of Clinical Apheresis, where his findings have shaped new perspectives in transfusion medicine and clinical diagnostics. Beyond research, Prof. Wu is also recognized for his mentorship and leadership in education, actively guiding emerging medical scientists and fostering collaboration, innovation, and integrity in research. His interdisciplinary approach and commitment to continuous improvement underscore his vision for integrating artificial intelligence, real-world data analytics, and precision-based methodologies into modern healthcare systems. Through his dedication to advancing transfusion science and promoting global standards in laboratory medicine, Prof. Ding Wen Wu continues to serve as an inspiring figure whose work contributes significantly to safer, more efficient, and patient-centered medical practices worldwide.

Profiles: Scopus | ORCID

Feaured Publications

Amro Othman | Polymerase Chain Reaction | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Amro Othman | Polymerase Chain Reaction | Best Researcher Award

Post doctoral Researcher | King Fahd University of Petroleum & Minerals | Saudi Arabia

Dr. Amro Othman, a faculty member at King Fahd University of Petroleum and Minerals, is an accomplished researcher whose work bridges fundamental science and industrial application in energy and fluid–rock interactions. His scholarship focuses on sustainable hydraulic fracturing fluids, chelating agents, and polymer rheology, with a strong emphasis on seawater-based and eco-friendly solutions. Through publications in Polymers, ACS Omega, and Energy & Fuels, Dr. Othman has advanced understanding of fluid–rock compatibility, kerogen properties, and AI-driven optimization of fracturing fluids. His Google Scholar record reflects his growing impact, with 112 citations, an h-index of 7, and an i10-index of 5. Notably, his most cited article, Chelating Agents Usage in Optimization of Fracturing Fluid Rheology Prepared from Seawater (Polymers, 2021), has garnered over 24 citations, while his subsequent studies on seawater-based fluid rheology and polymer–ion interactions continue to shape the field. Beyond publications, Dr. Othman has contributed to industry practice through conference papers and collaborative projects with major energy companies, reinforcing the practical relevance of his research. His leadership extends to mentoring, peer reviewing, and engaging in high-value interdisciplinary initiatives. Collectively, his innovative research trajectory, academic recognition, and applied contributions underscore his standing as a leading voice in petroleum engineering and materials science.

Profiles: ORCID | Google Scholar

Featured Publications

Alpana Kumari | Medical Terminology | Best Researcher Award

Published on by Medical Lab Scientist

Mrs. Alpana Kumari | Medical Terminology | Best Researcher Award

Assistant Professor | Chandigarh University | India

Alpana Kumari is an accomplished optometrist, academician, and researcher with expertise in clinical practice, higher education, and vision science. Currently serving as an Assistant Professor at Chandigarh University, she also contributes as Research Coordinator, NAAC/IQAC Coordinator, BOS Member, and Lab Coordinator, while pursuing her Ph.D. in Optometry. She holds a Master’s degree in Optometry from CT University and a Bachelor’s degree from Chitkara University, complementing her clinical experience as Consultant Optometrist at Grewal Eye Hospital and ASG Eye Hospital. Skilled in advanced diagnostic and therapeutic techniques, including glaucoma workups, LASIK/SMILE evaluations, ocular imaging, low vision rehabilitation, and vision therapy, she has applied her expertise both clinically and academically. Her research focuses on ocular diseases, pediatric eye care, and artificial intelligence in ophthalmology, resulting in publications in Scopus-, PubMed-, and IEEE-indexed journals, a book chapter with Elsevier, and two patents—an ophthalmic helmet glass with adjustable refractive power and a virtual simulation system for progressive vision disorders. Actively engaged in international conferences, faculty development programs, and academic workshops, she has been recognized with multiple awards for innovation, peer reviewing, and academic contributions. With a strong commitment to advancing clinical practice, research, and healthcare education, she continues to make impactful contributions to optometry and vision science.

Profile: ORCID

Featured Publications

Cara-Lynne Schengrund | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Cara-Lynne Schengrund | Biochemistry | Best Researcher Award

Professor | Penn State College of Medicine | United States

Dr. Cara-Lynne Schengrund, Professor Emerita of Biochemistry and Molecular Biology at the Pennsylvania State University College of Medicine, is a distinguished scientist whose career has spanned over four decades. She earned her B.S. in Chemistry from Upsala College and her M.S. and Ph.D. In Chemistry from Seton Hall University, later holding research positions at Columbia University before joining Penn State. Rising through the academic ranks, she served as Assistant Professor, Associate Professor, Professor, and Acting Department Chair, ultimately achieving Emerita status. Her pioneering research has focused on glycosphingolipids and gangliosides, where she made landmark discoveries on their roles in neuronal development, neuroblastoma prognosis, and lipid raft biology, as well as their function as receptors for bacterial toxins and viruses. Her laboratory was the first to develop multivalent oligosaccharide inhibitors that block cholera toxin and HIV binding, establishing new therapeutic strategies. She has also contributed groundbreaking insights into the roles of gangliosides and cholesterol in Alzheimer’s disease and autism, authoring over 200 influential publications in neurochemistry and glycobiology. Beyond research, Dr. Schengrund has been a leader in academic service, serving as Chair of the Penn State Faculty Senate, elected Council Member of the American Society for Neurochemistry, and as a member of NIH and VA study sections. Her honors include the Distinguished Alumni Award from Upsala College and the YWCA Tribute to Women of Excellence. Through her research, mentorship, and leadership, Dr. Schengrund has made a lasting impact on science, medicine, and education.

Profile: ORCID

Featured Publications

Umadevi Kandalam | Human Anatomy & Physiology | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Umadevi Kandalam | Human Anatomy & Physiology | Best Researcher Award

Associate Professor | Texas Tech University |United States

Dr. Umadevi Kandalam, PhD, is an accomplished academic and researcher currently serving as Associate Professor of Physiology at the Woody L. Hunt School of Dental Medicine, Texas Tech University Health Sciences Center El Paso, and as faculty at the L. Frederick Francis Graduate School of Biomedical Sciences. With more than 20 years of research experience and 15 years of teaching at undergraduate, predoctoral, and postgraduate levels, she has established herself as a leader in biomedical sciences and dental education. Her research expertise lies in stem cell biology, regenerative medicine, tissue engineering, and translational science, with more than 30 peer-reviewed publications and over 60 conference presentations to her credit. She has served as principal investigator on 14 funded projects, securing over $400,000 in external and institutional grants, and as co-investigator on several other funded studies. Dr. Kandalam has been instrumental in establishing biomedical core laboratory facilities at her institution, fostering a platform for cutting-edge research and mentoring. She has guided more than 50 predoctoral, postgraduate, and undergraduate students, many of whom have received awards, presented at national and international conferences, and co-authored scientific manuscripts. A dedicated educator, she has contributed significantly to curriculum design, implementation of active learning methodologies, and integrated clinical teaching approaches, including case-based and flipped classroom strategies. She has delivered invited talks and keynote addresses at global meetings and served on numerous academic and professional committees. Her contributions have been recognized with honors such as the Young Scientist Award, Faculty Scientific Research Award from AAOMS and Osteoscience Foundation, and multiple external funding recognition awards.

Profile: ORCID

Featured Publications

Liying Ren | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Liying Ren | Molecular Biology | Best Researcher Award

Liying Ren | Peking University |China

Ren Liying is a medical researcher in hepatology and oncology, currently pursuing her Ph.D. in Internal Medicine at the Peking University Hepatology Institute, Peking University People’s Hospital, under the mentorship of Professor Chen Hongsong. She earned her Bachelor’s degree in Clinical Medicine from Hubei University of Science and Technology and her Master’s degree from Guilin Medical University under Professor Liao Weijia, before advancing to doctoral studies. Her research focuses on hepatocellular carcinoma (HCC), with an emphasis on integrating molecular biology, imaging, and clinical practice to improve patient outcomes. Ren has authored and co-authored several impactful publications in respected journals, including Cancers, Journal of Hepatocellular Carcinoma, BMC Cancer, World Journal of Gastroenterology, and Cancer Medicine. As first author, her study in Cancers identified the tumor-suppressive role of hemopexin in HCC via TNF-α–mediated mitochondrial apoptosis, while her review explored radiomics and radiogenomics as tools to bridge imaging and molecular characterization in liver cancer. She has also contributed to predictive models and radiomics-based approaches for recurrence and prognosis stratification after surgical resection of HCC. With a strong clinical foundation and commitment to translational research, Ren represents a new generation of physician-scientists advancing precision medicine in liver disease and cancer.

profile: Google scholar

Featured Publications